Pacer Advisors »

Silverback Therapeutics shares owned by Pacer Advisors

Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by Pacer Advisors from 13F filings

Historical chart of Pacer Advisors investment in Silverback Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Silverback Therapeutics held by Pacer Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silverback Therapeutics by Pacer Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $5.3k 516 10.22

More positions owned by Pacer Advisors

Exxon Mobil Corp Common Stock - Domestic (XOM)
3M Common Stock - Domestic (MMM)
Valero Energy Corp Common Stock - Domestic (VLO)
Vistra Corp Common Stock - Domestic (VST)
Bristol-Myers Squibb Common Stock - Domestic (BMY)
Marathon Petroleum Corp Common Stock - Domestic (MPC)
Chevron Corp Common Stock - Domestic (CVX)
Altria Group Common Stock - Domestic (MO)
EOG Resources Common Stock - Domestic (EOG)
CVS Health Corp Common Stock - Domestic (CVS)
At&t Common Stock - Domestic (T)
United States Treasury Bill Treasury Bill (Principal)
Cisco Systems Common Stock - Domestic (CSCO)
Gilead Sciences Common Stock - Domestic (GILD)
Diamondback Energy Common Stock - Domestic (FANG)

View all positions for Pacer Advisors

Top funds holding Silverback Therapeutics

Deerfield Management Company
RA Capital Management
OrbiMed Advisors
Sr One Capital Management
Franklin Resources
Vanguard Group
BlackRock
K2 Principal Fund
Nextech Invest
State Street Corporation
FMR
Geode Capital Management
Perceptive Advisors
Rubric Capital Management
Royce & Associates

View all funds holding Silverback Therapeutics